top of page
it's where dermatology lives



AD biologic non-responders benefit from extended Tx
Photo by Dwxn via Wikimedia Commons New research reveals that patients with moderate-to-severe atopic dermatitis (AD) who did not...
John Evans
May 161 min read


Precise design of JAK inhibitors may improve outcomes in variety of diseases
A study from the Icahn School of Medicine at Mount Sinai in New York has reported some new insights into JAK inhibitors. While current...
Allan Ryan
Jan 15, 20242 min read


Improved understanding of pathways could lead to new hair loss therapies
A new finding from Mount Sinai (New York) researchers may have implications for the potential development of hair loss treatments. In a...
Allan Ryan
Jan 30, 20232 min read
Featured Posts




bottom of page

